DK1411960T3 - Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed - Google Patents
Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhedInfo
- Publication number
- DK1411960T3 DK1411960T3 DK02749618T DK02749618T DK1411960T3 DK 1411960 T3 DK1411960 T3 DK 1411960T3 DK 02749618 T DK02749618 T DK 02749618T DK 02749618 T DK02749618 T DK 02749618T DK 1411960 T3 DK1411960 T3 DK 1411960T3
- Authority
- DK
- Denmark
- Prior art keywords
- rice bran
- grams
- per
- milligrams
- vitamin
- Prior art date
Links
- 235000007164 Oryza sativa Nutrition 0.000 title abstract 11
- 235000009566 rice Nutrition 0.000 title abstract 11
- 235000013305 food Nutrition 0.000 title abstract 3
- 240000007594 Oryza sativa Species 0.000 title 1
- 230000036996 cardiovascular health Effects 0.000 title 1
- 241000209094 Oryza Species 0.000 abstract 10
- 241001465754 Metazoa Species 0.000 abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 1
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract 1
- 239000006014 omega-3 oil Substances 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Cereal-Derived Products (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/895,335 US6436431B1 (en) | 2001-07-02 | 2001-07-02 | Fortified rice bran food product and method for promoting cardiovascular health |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1411960T3 true DK1411960T3 (da) | 2006-07-24 |
Family
ID=25404356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02749618T DK1411960T3 (da) | 2001-07-02 | 2002-06-21 | Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6436431B1 (da) |
| EP (1) | EP1411960B1 (da) |
| JP (1) | JP4300109B2 (da) |
| AT (1) | ATE322276T1 (da) |
| CA (1) | CA2451704C (da) |
| DE (1) | DE60210465T2 (da) |
| DK (1) | DK1411960T3 (da) |
| ES (1) | ES2262820T3 (da) |
| IL (2) | IL159370A0 (da) |
| MX (1) | MXPA03012035A (da) |
| NO (1) | NO20035850L (da) |
| PT (1) | PT1411960E (da) |
| WO (1) | WO2003004044A1 (da) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6616942B1 (en) * | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
| US6623734B2 (en) * | 2000-06-22 | 2003-09-23 | Soft Gel Technologies, Inc. | Super absorption coenzyme Q10 |
| FR2847472B1 (fr) * | 2002-11-22 | 2006-08-11 | Synergia | Nouvelles compositions pharmaceutiques notamment pour la prevention des pathologies cardio-vasculaires |
| MXPA05010930A (es) * | 2003-04-17 | 2005-11-25 | Boehringer Ingelheim Int | Suplemento multivitaminico y mineral para mujeres embarazadas. |
| US20080089877A1 (en) * | 2003-08-14 | 2008-04-17 | Udell Ronald G | Super Absorption Coenzyme Q10 |
| US8124072B2 (en) * | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
| US7169385B2 (en) * | 2003-09-29 | 2007-01-30 | Ronald G. Udell | Solubilized CoQ-10 and carnitine |
| EP1670325A1 (en) | 2003-09-29 | 2006-06-21 | Soft Gel Technologies, Inc. | SOLUBILIZED CoQ-10 |
| US20050074443A1 (en) * | 2003-10-03 | 2005-04-07 | Treadwell Benjamin V. | Methods of attenuating autoimmune disease and compositions useful therefor |
| US7416752B2 (en) * | 2004-01-06 | 2008-08-26 | Sharp Ingrained Functional Foods, Inc. | Method of fortifying seeds with an essential fatty acid, fortified seed and food product |
| US20050147730A1 (en) * | 2004-01-06 | 2005-07-07 | Holub Bruce J. | Method of fortifying seeds with an essential fatty acid, fortified seed and food product |
| US20050267091A1 (en) * | 2004-05-25 | 2005-12-01 | Roger Berlin | Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses |
| US20060009486A1 (en) * | 2004-07-07 | 2006-01-12 | Gm Pharmaceuticals Inc. | Composition and method for treatment and prevention of coronary artery disease |
| US8101587B2 (en) | 2004-08-12 | 2012-01-24 | Everett Laboratories, Inc. | Kits for nutrition supplementation |
| US7700142B2 (en) * | 2005-05-16 | 2010-04-20 | Diane Wright Hoffpauer | Fortified cereal bran to promote digestive health |
| US7887852B2 (en) * | 2005-06-03 | 2011-02-15 | Soft Gel Technologies, Inc. | Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols |
| US20070212470A1 (en) * | 2006-03-13 | 2007-09-13 | Nutracea | Therapeutic uses of an anti-cancer composition derived from rice bran |
| US20080038385A1 (en) * | 2006-03-13 | 2008-02-14 | Nutracea | Therapeutic uses of an anti-cancer composition derived from rice bran |
| WO2008016701A2 (en) | 2006-08-02 | 2008-02-07 | Hammond Neal A | Biogenic silica from silica-containing plant material such as rice hulls |
| FI122915B (fi) | 2006-09-06 | 2012-08-31 | Cerefi Oy | Kylläisyyttä aiheuttava tuote |
| US8343541B2 (en) * | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
| US20080305214A1 (en) * | 2007-06-08 | 2008-12-11 | Barilla G. E R. Fratelli S.P.A. | Composition useful for the reduction of the cardiovascular risk and foods that contain it |
| EP2014180A1 (en) | 2007-07-08 | 2009-01-14 | Barilla G. e R. Fratelli S.p.A. | Composition useful for the reduction of the cardivascular risk and foods that contain it |
| ES2636564T3 (es) * | 2007-07-18 | 2017-10-06 | Sunstar Inc. | Composición de tipo salvado de arroz y alimento |
| JP5463526B2 (ja) * | 2008-03-21 | 2014-04-09 | 国立大学法人東京海洋大学 | 健康機能成分を吸着・濃縮した乾燥脱脂穀類糠、該糠から調製した健康機能成分の濃縮物、及びそれらの製造方法 |
| KR101938326B1 (ko) | 2017-07-21 | 2019-04-11 | 한국식품연구원 | 합성 카라멜 색소를 사용하지 않은 떡갈비 조성물 및 이의 제조방법 |
| WO2019149822A1 (en) * | 2018-02-02 | 2019-08-08 | Societe Des Produits Nestle S.A. | Stabilizing omega-3 fatty acids with bran |
| US20210260147A1 (en) * | 2020-02-25 | 2021-08-26 | Intermark Partners Strategic Management, Llc | Mitigation of chronic infant malnutrition |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59107305D1 (de) | 1990-05-22 | 1996-03-07 | Harold Bumann | Verfahren zur herstellung eines fruchtsaft-getränkes |
| US5326569A (en) * | 1992-12-23 | 1994-07-05 | Abbott Laboratories | Medical foods for the nutritional support of child/adult metabolic diseases |
| IT1274734B (it) | 1994-08-25 | 1997-07-24 | Prospa Bv | Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti |
| US5545414A (en) * | 1995-03-22 | 1996-08-13 | Abbott Laboratories | Cholesterol lowering food product |
| US5612074A (en) * | 1995-12-21 | 1997-03-18 | Leach; Robin L. | Nutrient fortified food bar |
| US5948443A (en) | 1996-02-23 | 1999-09-07 | Medical Doctor's Research Institute, Inc. | Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease |
| TW360501B (en) | 1996-06-27 | 1999-06-11 | Nestle Sa | Dietetically balanced milk product |
| CA2284290A1 (en) * | 1997-03-20 | 1998-09-24 | Samuel Russell Vester | Nutritional supplement for cardiovascular health |
| US6180660B1 (en) | 1997-08-26 | 2001-01-30 | Merck & Co., Inc. | Cholesterol-lowering therapy |
| US6126943A (en) | 1997-09-02 | 2000-10-03 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| US5952393A (en) | 1998-02-12 | 1999-09-14 | Sorkin, Jr.; Harlan Lee | Composition for reducing serum cholesterol levels |
| US6210686B1 (en) | 1998-12-18 | 2001-04-03 | Beth Israel Deaconess Medical Center | Dietary supplement and method for lowering risk of heart disease |
| EP1036510B1 (en) * | 1999-03-18 | 2004-01-07 | Bristol-Myers Squibb Company | Vitamin formulation for cardiovascular health |
-
2001
- 2001-07-02 US US09/895,335 patent/US6436431B1/en not_active Expired - Lifetime
-
2002
- 2002-06-21 EP EP02749618A patent/EP1411960B1/en not_active Expired - Lifetime
- 2002-06-21 DE DE60210465T patent/DE60210465T2/de not_active Expired - Lifetime
- 2002-06-21 PT PT02749618T patent/PT1411960E/pt unknown
- 2002-06-21 MX MXPA03012035A patent/MXPA03012035A/es active IP Right Grant
- 2002-06-21 DK DK02749618T patent/DK1411960T3/da active
- 2002-06-21 CA CA2451704A patent/CA2451704C/en not_active Expired - Fee Related
- 2002-06-21 AT AT02749618T patent/ATE322276T1/de not_active IP Right Cessation
- 2002-06-21 JP JP2003510055A patent/JP4300109B2/ja not_active Expired - Fee Related
- 2002-06-21 WO PCT/US2002/019589 patent/WO2003004044A1/en active IP Right Grant
- 2002-06-21 ES ES02749618T patent/ES2262820T3/es not_active Expired - Lifetime
- 2002-06-21 IL IL15937002A patent/IL159370A0/xx active IP Right Grant
-
2003
- 2003-12-15 IL IL159370A patent/IL159370A/en not_active IP Right Cessation
- 2003-12-30 NO NO20035850A patent/NO20035850L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2262820T3 (es) | 2006-12-01 |
| CA2451704C (en) | 2012-07-17 |
| JP2004537302A (ja) | 2004-12-16 |
| ATE322276T1 (de) | 2006-04-15 |
| CA2451704A1 (en) | 2003-01-16 |
| IL159370A (en) | 2006-07-05 |
| EP1411960B1 (en) | 2006-04-05 |
| DE60210465T2 (de) | 2006-11-30 |
| WO2003004044A1 (en) | 2003-01-16 |
| JP4300109B2 (ja) | 2009-07-22 |
| NO20035850L (no) | 2004-03-01 |
| IL159370A0 (en) | 2004-06-01 |
| MXPA03012035A (es) | 2005-08-16 |
| EP1411960A1 (en) | 2004-04-28 |
| DE60210465D1 (de) | 2006-05-18 |
| PT1411960E (pt) | 2006-08-31 |
| EP1411960A4 (en) | 2004-11-03 |
| US6436431B1 (en) | 2002-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1411960T3 (da) | Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed | |
| ES2187115T3 (es) | Preparado para lactantes. | |
| DE60229286D1 (de) | Lebensmittel oder tierfutter enthaltend die knochengesundheit unterstützendes pflanzenextrakt aus amelanchier | |
| CA2372614A1 (en) | Process and product for enhancing immune response in companion animal using a combination of antioxidants | |
| CY1108342T1 (el) | Ανοσορρυθμιστικοι ολιγοσακχαριτες | |
| MXPA04009765A (es) | Metodo para mejorar la absorcion de la vitamina e por una mascota animal. | |
| WO2006002976A3 (en) | Canine osteoarthritis diet formulation | |
| ATE258792T1 (de) | Diät mit hohem lipidgehalt | |
| TW200505470A (en) | Therapeutic agent | |
| TW200510308A (en) | Isophthalic acid derivatives | |
| WO2003068231A3 (de) | Mittel, enthaltend folsäure, vitamin b6 und vitamin b12, und dessen verwendung | |
| WO2000073274A3 (de) | Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung als adenosinaufnahme-inhibitoren | |
| ATE404519T1 (de) | Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen | |
| DE60209793D1 (de) | Modifierte methioninereiche nahrungsmittel und verfahren zu deren herstellung | |
| RU2001111308A (ru) | Способ профилактики нарушения белково-минерального обмена у телят при марганцевой недостаточности | |
| TH54050B (th) | เอทิลอีพีเอ ที่ทำให้บริสุทธิ์อย่างมากและอนุพันธ์อีพีเออื่นๆ ที่ใช้รักษาโรคทางจิตเวชและโรคทางประสาท | |
| TH54050A (th) | เอทิลอีพีเอ ที่ทำให้บริสุทธิ์อย่างมากและอนุพันธ์อีพีเออื่นๆ ที่ใช้รักษาโรคทางจิตเวชและโรคทางประสาท | |
| HUP9700432A2 (hu) | Magnéziumot és vitaminokat tartalmazó készítmények | |
| RO98918B1 (ro) | Produs medicamentos pentru tratamentul sindromului diareic acut infectios bacterian la tineretul animal |